• Management
• Company Information
• Group History / Mission Statement

IPC International Plc is a holding company under which an international group of pharmaceutical companies dealing in over the counter (OTC) and prescription (Rx) pharmaceutical products will develop.

The Group is currently predominantly represented in the Scandinavian countries. For more detailed information about our subsidiaries, please follow the relevant links on this website.

The Management has identified an under-exploited business opportunity in products that are too small in sales volume or turnover to be particularly interesting for the larger pharmaceutical companies. These companies are typically geared towards products with annual sales potential in excess of GBP 100 million. Numerous products below this level have been identified as being profitable and suitable for IPC, either directly or indirectly through partners.

It is the intention to develop a pan-European sales and distribution group for pharmaceutical products and devices through organic growth and acquisitions.

IPC’s acquisition targets will be selected on the basis of the potential value and synergy they will add to the group.

IPC’s longer term objective is to expand into countries outside the Nordic region. Acquisition targets in the UK, Norway, the Netherlands, Portugal, Spain, Greece, Poland and Ireland are currently under consideration.

The strategy for the next 12 to 36 months is to identify and potentially acquire small to medium-sized companies that fit IPC’s criteria. Such companies can either be acquired for cash, shares or through mergers. Due to our streamlined management structure and in-depth market knowledge we are able to complete the transaction very quickly once a target has been identified.